Published in Clin Exp Immunol on May 01, 1986
Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev (1997) 4.70
Contemporary issues: diseases with a food vector. Clin Microbiol Rev (1988) 1.31
Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci (2014) 1.03
Increased prevalence of non-secretors in patients with Graves' disease: evidence for an infective aetiology? Br Med J (Clin Res Ed) (1988) 0.94
Evaluation of a western blot method for the detection of Yersinia antibodies: evidence of serological cross-reactivity between Yersinia outer membrane proteins and Borrelia burgdorferi. Clin Diagn Lab Immunol (2005) 0.87
Graves' ophthalmopathy: a review of immunogenetics. Curr Genomics (2011) 0.84
Increased prevalence of antibodies to enteropathogenic Yersinia enterocolitica virulence proteins in relatives of patients with autoimmune thyroid disease. Clin Exp Immunol (2003) 0.83
Yersinia enterocolitica infection does not confer an increased risk of thyroid antibodies: evidence from a Danish twin study. Clin Exp Immunol (2006) 0.79
Comparison of Growth and the Cytokines Induced by Pathogenic Yersinia enterocolitica Bio-Serotypes 3/O: 3 and 2/O: 9. Front Cell Infect Microbiol (2017) 0.75
Lysis of gram-negative bacteria by lysozyme. Biochim Biophys Acta (1956) 5.31
An immunological cross-reaction between group-A streptococcal cells and human heart tissue. Lancet (1962) 4.78
Thyroid-stimulating immunoglobulins in Graves' disease. Lancet (1974) 2.84
Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis. N Engl J Med (1985) 1.26
Lymphocytotoxicity of anti-Klebsiella antisera in ankylosing spondylitis and related arthropathies: patient and family studies. Arthritis Rheum (1981) 1.18
Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica. Science (1983) 1.07
Thyroid-stimulating immunoglobulin bioassay using cultured human thyroid cells. J Clin Endocrinol Metab (1981) 1.01
Humoral immunity in Graves' disease. Clin Endocrinol Metab (1978) 1.01
Indirect immunofluorescence staining of human thyroid by antibodies occurring in Yersinia enterocolitica infections. Clin Exp Immunol (1976) 0.93
Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins. J Clin Invest (1984) 0.93
Thyrotropin receptors on bovine thyroid membranes: two types with different affinities and specificities. Endocrinology (1979) 0.92
The thyrotrophin receptor. Springer Semin Immunopathol (1982) 0.89
A new method for measurement of human thyroid-stimulating immunoglobulins. J Lab Clin Med (1980) 0.88
Partial purification and characterization of thyrotropin binding inhibitory immunoglobulins from normal human plasma. J Clin Endocrinol Metab (1983) 0.86
Reactive arthritis. Aust N Z J Med (1984) 0.82
Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells. Pediatr Infect Dis J (1987) 7.15
Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. J Infect Dis (1988) 5.30
Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia (2005) 4.87
Use of DNA probes and HEp-2 cell adherence assay to detect diarrheagenic Escherichia coli. J Infect Dis (1988) 3.19
Sharing of virulence-associated properties at the phenotypic and genetic levels between enteropathogenic Escherichia coli and Hafnia alvei. J Med Microbiol (1992) 3.03
Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet (2001) 2.54
Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature (1988) 2.46
Down syndrome and thyroid function in adults. Lancet (1975) 2.39
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology (2011) 2.39
Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes (1997) 2.19
Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest (1991) 2.07
MHCPEP, a database of MHC-binding peptides: update 1997. Nucleic Acids Res (1998) 2.02
IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans. J Immunol (1988) 1.83
Biosynthetic labeling of insulin receptor: studies of subunits in cultured human IM-9 lymphocytes. Proc Natl Acad Sci U S A (1981) 1.72
Insulin receptors, receptor antibodies, and the mechanism of insulin action. Recent Prog Horm Res (1981) 1.68
INS(GFP/w) human embryonic stem cells facilitate isolation of in vitro derived insulin-producing cells. Diabetologia (2011) 1.68
Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes (2000) 1.67
Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia (2004) 1.64
Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine (1998) 1.63
SPAK, a STE20/SPS1-related kinase that activates the p38 pathway. Oncogene (2000) 1.59
The sigA gene which is borne on the she pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation. Infect Immun (2000) 1.55
Purification of the insulin receptor from human placenta by chromatography on immobilized wheat germ lectin and receptor antibody. J Biol Chem (1980) 1.54
Immune characterization of an individual with an exceptionally high natural killer T cell frequency and her immediate family. Clin Exp Immunol (2009) 1.52
Neural network-based prediction of candidate T-cell epitopes. Nat Biotechnol (1998) 1.49
Autoantibodies to beta 2-adrenergic receptors: a possible cause of adrenergic hyporesponsiveness in allergic rhinitis and asthma. Science (1980) 1.48
The chronobiology of human cytokine production. Int Rev Immunol (1998) 1.47
Microtiter enzyme-linked immunosorbent assay for immunoglobulin G cholera antitoxin in humans: method and correlation with rabbit skin vascular permeability factor technique. Infect Immun (1980) 1.46
Binding of insulin receptors to lectins: evidence for common carbohydrate determinants on several membrane receptors. Biochemistry (1981) 1.45
Genetic organization of the she pathogenicity island in Shigella flexneri 2a. Microb Pathog (2001) 1.42
MHCPEP: a database of MHC-binding peptides. Nucleic Acids Res (1994) 1.41
Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects. J Clin Invest (1976) 1.40
Immunotherapy in pre-type 1 diabetes mellitus. Diabetologia (1990) 1.39
Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors. N Engl J Med (1978) 1.37
Intercellular adhesion molecule 1 is induced on isolated endocrine islet cells by cytokines but not by reovirus infection. Proc Natl Acad Sci U S A (1989) 1.32
Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med (1995) 1.28
Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man. Scand J Infect Dis Suppl (1982) 1.26
Subunit structure of the insulin receptor of the human lymphocyte. Biochemistry (1980) 1.25
Evaluation of a new, rapid and automated immunochemiluminometric assay for the measurement of serum intact parathyroid hormone. Ann Clin Biochem (1997) 1.25
Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes. J Immunol (2001) 1.23
Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? J Immunol (1997) 1.23
Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. Clin Infect Dis (1995) 1.21
Evidence for IL-6 production by and effects on the pancreatic beta-cell. J Immunol (1989) 1.20
Immunoprecipitation of the insulin receptor: a sensitive assay for receptor antibodies and a specific technique for receptor purification. J Clin Endocrinol Metab (1979) 1.20
Islet autoimmunity in infants with a Type I diabetic relative is common but is frequently restricted to one autoantibody. Diabetologia (2000) 1.20
Autoantibodies against the insulin receptor recognize the insulin binding subunits of an oligomeric receptor. Diabetes (1981) 1.18
T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Mol Med (1998) 1.17
The effect of solubilization on the properties of the insulin receptor of human placental membranes. Endocrinology (1978) 1.15
The effect of enterohemorrhagic Escherichia coli O157:H7 on intestinal structure and solute transport in rabbits. Gastroenterology (1993) 1.15
Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes. Diabetes (1989) 1.14
Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes. J Exp Med (1993) 1.13
Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes. J Immunol (1998) 1.13
Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine. Diabetes (1985) 1.13
Overview: the major histocompatibility complex and insulin dependent diabetes mellitus. Baillieres Clin Endocrinol Metab (1991) 1.11
Regulation of insulin receptors in normal and abnormal physiology in humans. Adv Intern Med (1979) 1.10
Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol Med (1995) 1.10
Duration of serum antitoxin response following Vibrio cholerae infection in North Americans: relevance for seroepidemiology. Am J Epidemiol (1981) 1.08
Direct evidence for the expression of multiple endogenous retroviruses in the synovial compartment in rheumatoid arthritis. Arthritis Rheum (1997) 1.08
MHCPEP, a database of MHC-binding peptides: update 1996. Nucleic Acids Res (1997) 1.07
HLA antigens and age at diagnosis of insulin-dependent diabetes mellitus. Hum Immunol (1995) 1.07
Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science (1996) 1.06
Interferon-gamma enhances the expression of the major histocompatibility class I antigens on mouse pancreatic beta cells. Diabetes (1985) 1.06
The human placenta contains two distinct binding and immunoreactive species of insulin-like growth factor-I receptors. J Biol Chem (1985) 1.06
Lack of association between duration of breast-feeding or introduction of cow's milk and development of islet autoimmunity. Diabetes (1999) 1.06
Insulin binding leads to the formation of covalent (-S-S-) hormone receptor complexes. J Biol Chem (1982) 1.04
Laminin-1 promotes differentiation of fetal mouse pancreatic beta-cells. Diabetes (1999) 1.04
IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse. J Immunol (1988) 1.04
The potential roles of endogenous retroviruses in autoimmunity. Immunol Rev (1996) 1.04
Cloning and partial nucleotide sequence of human glutamic acid decarboxylase cDNA from brain and pancreatic islets. Biochem Biophys Res Commun (1991) 1.03
High level of concordance between assays for glutamic acid decarboxylase antibodies. The First International Glutamic Acid Decarboxylase Antibody Workshop. Diabetes (1994) 1.03
D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine. Br Med J (1980) 1.01
Molecular pathology of type 1 diabetes. Mol Biol Med (1990) 1.00
Regulation of MHC protein expression in pancreatic beta-cells by interferon-gamma and tumor necrosis factor-alpha. Mol Endocrinol (1988) 0.99
Cytokine-based human whole blood assay for the detection of antigen-reactive T cells. J Immunol Methods (1995) 0.98
Heterogeneity of the insulin-receptor interaction in lipoatropic diabetes. J Clin Endocrinol Metab (1981) 0.97
Cytotoxic T cells to an epitope in the islet autoantigen IA-2 are not disease-specific. Clin Immunol (2001) 0.97
Reduction in insulitis following administration of IFN-gamma and TNF-alpha in the NOD mouse. J Autoimmun (1991) 0.97
Reovirus infection enhances expression of class I MHC proteins on human beta-cell and rat RINm5F cell. Diabetes (1988) 0.96
Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes. Proc Natl Acad Sci U S A (1992) 0.96
Structural differences between insulin and somatomedin-C/insulin-like growth factor-1 receptors revealed by autoantibodies to the insulin receptor. Biochem Biophys Res Commun (1982) 0.96
Retroviral superantigens and type 1 diabetes mellitus. Cell (1998) 0.96
T-cell antigen receptor transmembrane peptides modulate T-cell function and T cell-mediated disease. Nat Med (1997) 0.96
Analysis of clinical and environment Yersinia isolates in the Republic of Georgia. J Clin Microbiol (1996) 0.95
Acquisition of resistance by Salmonella typhi in vivo: the importance of plasmid characterisation. Lancet (1982) 0.95
Localization and quantitation of expression of two glutamate decarboxylase genes in pancreatic beta-cells and other peripheral tissues of mouse and rat. Endocrinology (1993) 0.95
Hemagglutinating properties of enteroaggregative Escherichia coli. J Clin Microbiol (1994) 0.95
The beta cell in autoimmune diabetes: many mechanisms and pathways of loss. Trends Endocrinol Metab (2001) 0.94
Mucosal antigen primes diabetogenic cytotoxic T-lymphocytes regardless of dose or delivery route. Diabetes (2001) 0.94
Report from the 1st International NOD Mouse T-Cell Workshop and the follow-up mini-workshop. Diabetes (2001) 0.94
Identification of pancreatic beta cell-related genes by representational difference analysis. Endocrinology (1997) 0.94
Fuzzy neural network-based prediction of the motif for MHC class II binding peptides. J Biosci Bioeng (2001) 0.94
IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes. Hum Immunol (1998) 0.93
The A-chain of insulin is a hot-spot for CD4+ T cell epitopes in human type 1 diabetes. Clin Exp Immunol (2009) 0.93
Evidence that macrophages are required for T-cell infiltration and rejection of fetal pig pancreas xenografts in nonobese diabetic mice. Transplantation (1998) 0.93
An atypical insulin receptor with high affinity for insulin-like growth factors copurified with placental insulin receptors. Proc Natl Acad Sci U S A (1986) 0.93
Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins. J Clin Invest (1984) 0.93
Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes. J Exp Med (1992) 0.92
Innate and adaptive immune responses to nonvascular xenografts: evidence that macrophages are direct effectors of xenograft rejection. J Immunol (2001) 0.92
MHCPEP--a database of MHC-binding peptides: update 1995. Nucleic Acids Res (1996) 0.92
Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-gamma antibody. Diabetologia (1991) 0.92